The effect of orofacial complete Freund’s adjuvant treatment on the expression of migraine-related molecules

Abstract Background Migraine is a neurovascular primary headache disorder, which causes significant socioeconomic problems worldwide. The pathomechanism of disease is enigmatic, but activation of the trigeminovascular system (TS) appears to be essential during the attack. Migraine research of recent...

Full description

Bibliographic Details
Main Authors: Tamás Körtési, Bernadett Tuka, Aliz Nyári, László Vécsei, János Tajti
Format: Article
Language:English
Published: BMC 2019-04-01
Series:The Journal of Headache and Pain
Subjects:
CFA
Online Access:http://link.springer.com/article/10.1186/s10194-019-0999-7
id doaj-f364f8c0359e47788f4d4ce9acd7318b
record_format Article
spelling doaj-f364f8c0359e47788f4d4ce9acd7318b2020-11-25T03:28:49ZengBMCThe Journal of Headache and Pain1129-23691129-23772019-04-012011910.1186/s10194-019-0999-7The effect of orofacial complete Freund’s adjuvant treatment on the expression of migraine-related moleculesTamás Körtési0Bernadett Tuka1Aliz Nyári2László Vécsei3János Tajti4Department of Neurology, Faculty of Medicine, Albert Szent-Györgyi Clinical Center University of SzegedMTA-SZTE Neuroscience Research Group, University of SzegedDepartment of Neurology, Faculty of Medicine, Albert Szent-Györgyi Clinical Center University of SzegedMTA-SZTE Neuroscience Research Group, University of SzegedDepartment of Neurology, Faculty of Medicine, Albert Szent-Györgyi Clinical Center University of SzegedAbstract Background Migraine is a neurovascular primary headache disorder, which causes significant socioeconomic problems worldwide. The pathomechanism of disease is enigmatic, but activation of the trigeminovascular system (TS) appears to be essential during the attack. Migraine research of recent years has focused on neuropeptides, such as calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase-activating polypeptide 1–38 (PACAP1–38) as potential pathogenic factors and possible therapeutic offensives. The goal of present study was to investigate the simultaneous expression of CGRP and precursor of PACAP1–38 (preproPACAP) in the central region of the TS in a time-dependent manner following TS activation in rats. Methods The right whisker pad of rats was injected with 50 μl Complete Freund’s Adjuvant (CFA) or saline. A mechanical allodynia test was performed with von Frey filaments before and after treatment. Transcardial perfusion of the animals was initiated 24, 48, 72 and 120 h after injection, followed by the dissection of the nucleus trigeminus caudalis (TNC). After preparation, the samples were stored at − 80 °C until further use. The relative optical density of CGRP and preproPACAP was analyzed by Western blot. One-way ANOVA and Kruskal-Wallis followed by Tukey post hoc test were used to evaluate the data. Regression analysis was applied to explore the correlation between neuropeptides expression and hyperalgesia. Results Orofacial CFA injection resulted in significant CGRP and preproPACAP release in the TNC 24, 48, 72 and 120 h after the treatment. The level of neuropeptides reached its maximum at 72 h after CFA injection, corresponding to the peak of facial allodynia. Negative, linear correlation was detected between the expression level of neuropeptides and value of mechanonociceptive threshold. Conclusion This is the first study which suggests that the expression of CGRP and preproPACAP simultaneously increases in the central region of activated TS and it influences the formation of mechanical hyperalgesia. Our results contribute to a better understanding of migraine pathogenesis and thereby to the development of more effective therapeutic approaches.http://link.springer.com/article/10.1186/s10194-019-0999-7MigraineTrigeminovascular systemCFACGRPpreproPACAP
collection DOAJ
language English
format Article
sources DOAJ
author Tamás Körtési
Bernadett Tuka
Aliz Nyári
László Vécsei
János Tajti
spellingShingle Tamás Körtési
Bernadett Tuka
Aliz Nyári
László Vécsei
János Tajti
The effect of orofacial complete Freund’s adjuvant treatment on the expression of migraine-related molecules
The Journal of Headache and Pain
Migraine
Trigeminovascular system
CFA
CGRP
preproPACAP
author_facet Tamás Körtési
Bernadett Tuka
Aliz Nyári
László Vécsei
János Tajti
author_sort Tamás Körtési
title The effect of orofacial complete Freund’s adjuvant treatment on the expression of migraine-related molecules
title_short The effect of orofacial complete Freund’s adjuvant treatment on the expression of migraine-related molecules
title_full The effect of orofacial complete Freund’s adjuvant treatment on the expression of migraine-related molecules
title_fullStr The effect of orofacial complete Freund’s adjuvant treatment on the expression of migraine-related molecules
title_full_unstemmed The effect of orofacial complete Freund’s adjuvant treatment on the expression of migraine-related molecules
title_sort effect of orofacial complete freund’s adjuvant treatment on the expression of migraine-related molecules
publisher BMC
series The Journal of Headache and Pain
issn 1129-2369
1129-2377
publishDate 2019-04-01
description Abstract Background Migraine is a neurovascular primary headache disorder, which causes significant socioeconomic problems worldwide. The pathomechanism of disease is enigmatic, but activation of the trigeminovascular system (TS) appears to be essential during the attack. Migraine research of recent years has focused on neuropeptides, such as calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase-activating polypeptide 1–38 (PACAP1–38) as potential pathogenic factors and possible therapeutic offensives. The goal of present study was to investigate the simultaneous expression of CGRP and precursor of PACAP1–38 (preproPACAP) in the central region of the TS in a time-dependent manner following TS activation in rats. Methods The right whisker pad of rats was injected with 50 μl Complete Freund’s Adjuvant (CFA) or saline. A mechanical allodynia test was performed with von Frey filaments before and after treatment. Transcardial perfusion of the animals was initiated 24, 48, 72 and 120 h after injection, followed by the dissection of the nucleus trigeminus caudalis (TNC). After preparation, the samples were stored at − 80 °C until further use. The relative optical density of CGRP and preproPACAP was analyzed by Western blot. One-way ANOVA and Kruskal-Wallis followed by Tukey post hoc test were used to evaluate the data. Regression analysis was applied to explore the correlation between neuropeptides expression and hyperalgesia. Results Orofacial CFA injection resulted in significant CGRP and preproPACAP release in the TNC 24, 48, 72 and 120 h after the treatment. The level of neuropeptides reached its maximum at 72 h after CFA injection, corresponding to the peak of facial allodynia. Negative, linear correlation was detected between the expression level of neuropeptides and value of mechanonociceptive threshold. Conclusion This is the first study which suggests that the expression of CGRP and preproPACAP simultaneously increases in the central region of activated TS and it influences the formation of mechanical hyperalgesia. Our results contribute to a better understanding of migraine pathogenesis and thereby to the development of more effective therapeutic approaches.
topic Migraine
Trigeminovascular system
CFA
CGRP
preproPACAP
url http://link.springer.com/article/10.1186/s10194-019-0999-7
work_keys_str_mv AT tamaskortesi theeffectoforofacialcompletefreundsadjuvanttreatmentontheexpressionofmigrainerelatedmolecules
AT bernadetttuka theeffectoforofacialcompletefreundsadjuvanttreatmentontheexpressionofmigrainerelatedmolecules
AT aliznyari theeffectoforofacialcompletefreundsadjuvanttreatmentontheexpressionofmigrainerelatedmolecules
AT laszlovecsei theeffectoforofacialcompletefreundsadjuvanttreatmentontheexpressionofmigrainerelatedmolecules
AT janostajti theeffectoforofacialcompletefreundsadjuvanttreatmentontheexpressionofmigrainerelatedmolecules
AT tamaskortesi effectoforofacialcompletefreundsadjuvanttreatmentontheexpressionofmigrainerelatedmolecules
AT bernadetttuka effectoforofacialcompletefreundsadjuvanttreatmentontheexpressionofmigrainerelatedmolecules
AT aliznyari effectoforofacialcompletefreundsadjuvanttreatmentontheexpressionofmigrainerelatedmolecules
AT laszlovecsei effectoforofacialcompletefreundsadjuvanttreatmentontheexpressionofmigrainerelatedmolecules
AT janostajti effectoforofacialcompletefreundsadjuvanttreatmentontheexpressionofmigrainerelatedmolecules
_version_ 1724582510394867712